PTIL Protherics (MM)

Protherics PLC

Total Voting Rights and Share Capital


London, UK; Brentwood, TN; 2 October 2008 - In conformity with the
Transparency Directive, Protherics PLC ("Protherics"), the
international biopharmaceutical company focused on critical care and
cancer, notifies the market of the following:

Protherics' issued share capital consists of
342,450,241 ordinary shares with a nominal value of 2 pence each, with
voting rights. Protherics does not hold any ordinary shares in
Treasury.  Therefore, the total number of voting rights
in Protherics is 342,450,241.

The above figure may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to
notify their interest in, or a change to their interest
in, Protherics under the Financial Services Authority's Disclosure and
Transparency Rules.


/ Ends /



For further information please contact:

Protherics
Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510
Julie Vickers, Company Secretary            +44 (0)1928 518010

Financial Dynamics - press enquiries
London: Ben Atwell, Lara Mott               +44 (0) 20 7831 3113
New York: John Capodanno                    +1 212 850 5600

Or visit  www.protherics.com

                    This information is provided by RNS
          The company news service from the London Stock Exchange

END

Contacts: RNS Customer Services 0044-207797-4400 Email Contact http://www.rns.com

Protherics (NASDAQ:PTIL)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Protherics (NASDAQ:PTIL)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024